Search research articles
Contact Us
Filters
Showing results (121-130 of 218) with videos related to
Page
of 22
Sort By:
European Journal of Haematology
|
October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival
Helen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
G3 (Bethesda, Md.)
|
August 12, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogens
Sun Lee, Caroline West, Dana A Opulente, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogens
Sun Lee, Caroline West, Dana A Opulente, et al.
British Journal of Haematology
|
July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis
Animesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
Plos Biology
|
September 23, 2024
Diverse signatures of convergent evolution in cactus-associated yeasts
Carla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Diverse signatures of convergent evolution in cacti-associated yeasts
Carla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2024
Saccharomycotina yeasts defy long-standing macroecological patterns
Kyle T David, Marie-Claire Harrison, Dana A Opulente, et al.
Developmental Biology
|
August 19, 2018
CBD-1 organizes two independent complexes required for eggshell vitelline layer formation and egg activation in C. elegans
Delfina P González, Helen V Lamb, Diana Partida, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Saccharomycotina yeasts defy longstanding macroecological patterns
Kyle T David, Marie-Claire Harrison, Dana A Opulente, et al.
Future Oncology (London, England)
|
March 7, 2026
POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib
Pankit Vachhani, Abdulraheem Yacoub, Raajit Rampal, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 218) with videos related to
Sort By:
Page
of 22
European Journal of Haematology
|
October 14, 2024
Pacritinib Response Is Associated With Overall Survival in Myelofibrosis: PERSIST-2 Landmark Analysis of Survival
Helen Ajufo, Jan Philipp Bewersdorf, Claire Harrison, et al.
G3 (Bethesda, Md.)
|
August 12, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogens
Sun Lee, Caroline West, Dana A Opulente, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
Genomic factors limiting the diversity of Saccharomycotina plant pathogens
Sun Lee, Caroline West, Dana A Opulente, et al.
British Journal of Haematology
|
July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis
Animesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
Plos Biology
|
September 23, 2024
Diverse signatures of convergent evolution in cactus-associated yeasts
Carla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
Diverse signatures of convergent evolution in cacti-associated yeasts
Carla Gonçalves, Marie-Claire Harrison, Jacob L Steenwyk, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2024
Saccharomycotina yeasts defy long-standing macroecological patterns
Kyle T David, Marie-Claire Harrison, Dana A Opulente, et al.
Developmental Biology
|
August 19, 2018
CBD-1 organizes two independent complexes required for eggshell vitelline layer formation and egg activation in C. elegans
Delfina P González, Helen V Lamb, Diana Partida, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Saccharomycotina yeasts defy longstanding macroecological patterns
Kyle T David, Marie-Claire Harrison, Dana A Opulente, et al.
Future Oncology (London, England)
|
March 7, 2026
POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib
Pankit Vachhani, Abdulraheem Yacoub, Raajit Rampal, et al.
Page
of 22